NO852563L - Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.Info
- Publication number
- NO852563L NO852563L NO852563A NO852563A NO852563L NO 852563 L NO852563 L NO 852563L NO 852563 A NO852563 A NO 852563A NO 852563 A NO852563 A NO 852563A NO 852563 L NO852563 L NO 852563L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- pyridine derivatives
- therapeutic active
- active pyridine
- Prior art date
Links
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F21—LIGHTING
- F21V—FUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR
- F21V7/00—Reflectors for light sources
- F21V7/04—Optical design
- F21V7/08—Optical design with elliptical curvature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8410108A FR2566775B1 (fr) | 1984-06-27 | 1984-06-27 | Derives de tetrahydro-4,5,6,7 furo ou 1h-pyrrolo(2,3-c)pyridine, leur preparation et leur application en therapeutique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO852563L true NO852563L (no) | 1985-12-30 |
| NO161742B NO161742B (no) | 1989-06-12 |
| NO161742C NO161742C (no) | 1989-09-20 |
Family
ID=9305484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO852563A NO161742C (no) | 1984-06-27 | 1985-06-26 | Analogifremgangsm te for fremstilling av terapeutisk aktive pyridinderivater. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4621087A (no) |
| EP (1) | EP0170549B1 (no) |
| JP (1) | JPS6118778A (no) |
| KR (1) | KR860000283A (no) |
| AR (1) | AR240820A1 (no) |
| AT (1) | ATE40367T1 (no) |
| AU (1) | AU573856B2 (no) |
| CA (1) | CA1273340A (no) |
| DE (1) | DE3567869D1 (no) |
| DK (1) | DK158952C (no) |
| ES (1) | ES8604583A1 (no) |
| FI (1) | FI82052C (no) |
| FR (1) | FR2566775B1 (no) |
| GR (1) | GR851567B (no) |
| HU (1) | HU192236B (no) |
| IL (1) | IL75632A0 (no) |
| MX (1) | MX156795A (no) |
| NO (1) | NO161742C (no) |
| NZ (1) | NZ212556A (no) |
| PT (1) | PT80718B (no) |
| ZA (1) | ZA854827B (no) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2635977B1 (fr) * | 1988-09-07 | 1992-05-15 | Synthelabo | Utilisation de derives de tetrahydro-4,5,6,7 furopyridines pour obtenir des medicaments destines au traitement de l'obesite |
| CA1337695C (en) * | 1988-09-23 | 1995-12-05 | Jacques Gosteli | Process for the production of 4,5,6,7-tetrahydrothieno-¬3,2-c|-pyridines |
| EP1147113B1 (en) | 1999-01-19 | 2006-06-07 | Neurosearch A/S | Fused heterocyclic compounds and their use in the treatment of neurodegenerative diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2215948B1 (no) * | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma | |
| US4075215A (en) * | 1973-02-01 | 1978-02-21 | Centre D'etudes Pour L'industrie Pharmaceutique | Thieno-pyridine derivatives |
| GB1484140A (en) * | 1974-04-24 | 1977-08-24 | Wyeth John & Brother Ltd | Pyrrolopyridine derivatives |
| US4520025A (en) * | 1982-07-21 | 1985-05-28 | William H. Rorer, Inc. | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
| IL71661A0 (en) * | 1983-04-27 | 1984-07-31 | Boehringer Ingelheim Kg | 4-phenyl-tetrahydro-furano-pyridines,their preparation and pharmaceutical compositions containing them |
| FR2570701B1 (fr) * | 1984-09-27 | 1987-05-22 | Synthelabo | Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique |
-
1984
- 1984-06-27 FR FR8410108A patent/FR2566775B1/fr not_active Expired
-
1985
- 1985-06-18 EP EP85401198A patent/EP0170549B1/fr not_active Expired
- 1985-06-18 AT AT85401198T patent/ATE40367T1/de not_active IP Right Cessation
- 1985-06-18 DE DE8585401198T patent/DE3567869D1/de not_active Expired
- 1985-06-25 MX MX205767A patent/MX156795A/es unknown
- 1985-06-26 US US06/748,765 patent/US4621087A/en not_active Expired - Fee Related
- 1985-06-26 IL IL75632A patent/IL75632A0/xx not_active IP Right Cessation
- 1985-06-26 PT PT80718A patent/PT80718B/pt not_active IP Right Cessation
- 1985-06-26 KR KR1019850004557A patent/KR860000283A/ko not_active Application Discontinuation
- 1985-06-26 JP JP60141457A patent/JPS6118778A/ja active Pending
- 1985-06-26 CA CA000485324A patent/CA1273340A/en not_active Expired - Fee Related
- 1985-06-26 AU AU44177/85A patent/AU573856B2/en not_active Ceased
- 1985-06-26 ES ES544564A patent/ES8604583A1/es not_active Expired
- 1985-06-26 ZA ZA854827A patent/ZA854827B/xx unknown
- 1985-06-26 NZ NZ212556A patent/NZ212556A/en unknown
- 1985-06-26 GR GR851567A patent/GR851567B/el unknown
- 1985-06-26 FI FI852523A patent/FI82052C/fi not_active IP Right Cessation
- 1985-06-26 NO NO852563A patent/NO161742C/no unknown
- 1985-06-26 DK DK288685A patent/DK158952C/da not_active IP Right Cessation
- 1985-06-26 HU HU852509A patent/HU192236B/hu unknown
- 1985-06-27 AR AR300830A patent/AR240820A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| GR851567B (no) | 1985-11-25 |
| AU573856B2 (en) | 1988-06-23 |
| PT80718B (fr) | 1987-04-23 |
| MX156795A (es) | 1988-10-04 |
| AR240820A1 (es) | 1991-02-28 |
| DK288685A (da) | 1985-12-28 |
| FR2566775B1 (fr) | 1986-10-31 |
| FI82052B (fi) | 1990-09-28 |
| FI852523A0 (fi) | 1985-06-26 |
| FI82052C (fi) | 1991-01-10 |
| EP0170549A1 (fr) | 1986-02-05 |
| US4621087A (en) | 1986-11-04 |
| NO161742C (no) | 1989-09-20 |
| ES544564A0 (es) | 1986-02-01 |
| KR860000283A (ko) | 1986-01-27 |
| DK158952C (da) | 1991-01-21 |
| FI852523L (fi) | 1985-12-28 |
| AR240820A2 (es) | 1991-02-28 |
| HUT38345A (en) | 1986-05-28 |
| AU4417785A (en) | 1986-01-02 |
| JPS6118778A (ja) | 1986-01-27 |
| ATE40367T1 (de) | 1989-02-15 |
| FR2566775A1 (fr) | 1986-01-03 |
| HU192236B (en) | 1987-05-28 |
| DE3567869D1 (en) | 1989-03-02 |
| ES8604583A1 (es) | 1986-02-01 |
| PT80718A (fr) | 1985-07-01 |
| NZ212556A (en) | 1987-10-30 |
| NO161742B (no) | 1989-06-12 |
| IL75632A0 (en) | 1985-10-31 |
| CA1273340A (en) | 1990-08-28 |
| DK288685D0 (da) | 1985-06-26 |
| EP0170549B1 (fr) | 1989-01-25 |
| DK158952B (da) | 1990-08-06 |
| ZA854827B (en) | 1986-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO853293L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater. | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO853046L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater. | |
| NO164025C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO883974L (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO162514C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater. | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO870526D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO853100L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazo-pyridiner. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO862956L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater. | |
| NO161497C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater. | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO164541C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater. | |
| NO875488L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO164897C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO864101L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO162617C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske imidazolderivater. | |
| NO162072C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater. | |
| NO890607L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. | |
| NO854277L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 6-fenetylaminoalkyl-7-hydroksy-furo-(3,4-c)-pyridin-derivater. |